DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Gingipain R
Gingipain R
Oleoresins and Naturally Occurring Compounds of Copaifera Genus As
Quercetin Inhibits Virulence Properties of Porphyromas Gingivalis In
Propeptide-Mediated Inhibition of Cognate Gingipain Proteinases
Role of Coagulation Factor 2 Receptor During Respiratory Pneumococcal Infections
Serine Proteases with Altered Sensitivity to Activity-Modulating
The Role of Tannerella Forsythia and Porphyromonas Gingivalis in Pathogenesis of Esophageal Cancer Bartosz Malinowski1, Anna Węsierska1, Klaudia Zalewska1, Maya M
^ P X R, for the PURPOSES of INFORMATION ONLY
Targeting a Cysteine Protease from a Pathobiont Alleviates Experimental
Caspases: Pharmacological Manipulation of Cell Death Inna N
Catalytic Residues in Hydrolases: Analysis of Methods Designed for Ligand-Binding Site Prediction
A New Insight Into Phagocytosis of Apoptotic Cells: Proteolytic Enzymes Divert the Recognition and Clearance of Polymorphonuclear Leukocytes by Macrophages
Epidemiology and Pathogenesis of Moraxella Catarrhalis Colonization
Families and Clans of Cysteine Peptidases
Inhibition of Gingipains by Their Profragments As the Mechanism Protecting Porphyromonas Gingivalis Against Premature Activation of Secreted Proteases
Microbial Extracellular Enzymes in Marine Sediments: Methods Development and Potential Activities in the Baltic Sea Deep Biosphere
Mechanistic and Structural Studies on Legumain Explain Its Zymogenicity, Distinct Activation Pathways, and Regulation
(12) Patent Application Publication (10) Pub. No.: US 2004/0231060 A1 Burdette Et Al
Discovery of High Affinity Receptors for Dityrosine Through Inverse Virtual Screening and Docking and Molecular Dynamics
Top View
Porphyromonas Gingivalis Uses Specific Domain Rearrangements and Allelic Exchange to Generate Diversity in Surface Virulence Factors
All Enzymes in BRENDA™ the Comprehensive Enzyme Information System
Crystal Structure of Gingipain R: an Arg-Specific Bacterial Cysteine
Papain-Like Proteases: Applications of Their Inhibitors
Design, Synthesis, and Evaluation of Cysteine Protease Inhibitors
GINGIPAINS”- a Pathogenic Virulent Factor for Periodontal Diseases
Proteolytic Processing and Activation of Gingipain Zymogens Secreted by T9SS of Porphyromonas Gingivalis
Pathophysiological Actions of Protease Activated Receptors (Pars)
Identification, Classification and Expression Pattern Analysis of Sugarcane Cysteine Proteinases
Porphyromonas Gingivalis Gingipains Induce a Pro-Inflammatory Extracellular Microenvironment : the Role of PAR-2 and Fibronectin
Protease-Activated Receptors (Pars): Mechanisms of Action and Potential Therapeutic Modulators in PAR-Driven Inflammatory Diseases Dorothea M
United States Patent (10) Patent No.: US 8,137,477 B2 Wittorffi Et All E 45) Date of Patent : Mar.E 20, 2012
Cathepsin S Signals Via PAR2 and Generates a Novel Tethered Ligand Receptor Agonist
Type IX Secretion System : Characterization of an Effector Protein and an Insight Into the Role of C-Terminal Domain Dimeration in Outer Membrane Translocation
Parkinson's Disease Cases Have No
Cardiovascular Disease and the Role of Oral Bacteria Shaneen J
Structure and Mechanism of Cysteine Peptidase Kgp, a Major Virulence Factor of Porphyromonas Gingivalis in Periodontitis **
Gingipains As a Virulence Factor in the Oral Cavity